Skip to main content
Clinical Trials/ACTRN12610000311055
ACTRN12610000311055
Completed
未知

A pilot, randomised controlled trial of retinal artery flicker induced vasodilatation to detect change in endothelial function in participants with obstructive sleep apnoea treated with continuous postitive airway pressure for 6 weeks.

Austin Health Department of Cardiology and Institute for Breathing and Sleep0 sites30 target enrollmentApril 19, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
Endothelial function
Sponsor
Austin Health Department of Cardiology and Institute for Breathing and Sleep
Enrollment
30
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 19, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Austin Health Department of Cardiology and Institute for Breathing and Sleep

Eligibility Criteria

Inclusion Criteria

  • Moderate to severe Obstructive Sleep Apnoea(OSA) \- Apnoea Hypopnoea Index greater than or equal to 30, with associated hypoxaemia – Oxygen saturation(Sa O2\) \<90% for a minimumm of 6% of total sleep time.
  • Actual coronary artery disease or two or more of the following cardiovascular risk factors – hypertension, dyslipidaemia, diabetes, smoking, positive family history.

Exclusion Criteria

  • Commercial driver or patients listed for urgent CPAP implementation.

Outcomes

Primary Outcomes

Not specified

Similar Trials